drugset

drugset / Trial / NCT00310765

Pregabalin for Abdominal Pain From Adhesions

NCT00310765 ↗

Phase 4 Terminated 18 enrolled Henry Ford Health System Pfizer · collab

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate if pregabalin demonstrates significant reduction in abdominal pain from adhesions.

Timeline

Start: 2006-03
Primary completion: 2008-08
Completion: 2008-08

Publications

Results Silverman A, Samuels Q, Gikas H, Nawras A. Pregabalin for the treatment of abdominal adhesion pain: a randomized, double-blind, placebo-controlled trial. Am J Ther. 2012 Nov;19(6):419-28. doi: 10.1097/MJT.0b013e318217a5f5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pregabalin	Small molecule	150 mg	Oral

Indications

No indication recorded.